These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1084 related articles for article (PubMed ID: 30109481)

  • 21. The role of IL 23 in the treatment of psoriasis.
    Puig L
    Expert Rev Clin Immunol; 2017 Jun; 13(6):525-534. PubMed ID: 28165883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in Understanding the Immunological Pathways in Psoriasis.
    Georgescu SR; Tampa M; Caruntu C; Sarbu MI; Mitran CI; Mitran MI; Matei C; Constantin C; Neagu M
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30744173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Responsiveness of Serum C-Reactive Protein, Interleukin-17A, and Interleukin-17F Levels to Ustekinumab in Psoriatic Arthritis: Lessons From Two Phase III, Multicenter, Double-Blind, Placebo-Controlled Trials.
    Siebert S; Sweet K; Dasgupta B; Campbell K; McInnes IB; Loza MJ
    Arthritis Rheumatol; 2019 Oct; 71(10):1660-1669. PubMed ID: 31070869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-17 family cytokines in protective immunity against infections: role of hematopoietic cell-derived and non-hematopoietic cell-derived interleukin-17s.
    Matsuzaki G; Umemura M
    Microbiol Immunol; 2018 Jan; 62(1):1-13. PubMed ID: 29205464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "alarmins" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis.
    Hegyi Z; Zwicker S; Bureik D; Peric M; Koglin S; Batycka-Baran A; Prinz JC; Ruzicka T; Schauber J; Wolf R
    J Invest Dermatol; 2012 May; 132(5):1416-24. PubMed ID: 22402441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis.
    Vecellio M; Hake VX; Davidson C; Carena MC; Wordsworth BP; Selmi C
    Front Immunol; 2020; 11():596086. PubMed ID: 33574815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis.
    Killeen ME; Ferris L; Kupetsky EA; Falo L; Mathers AR
    J Immunol; 2013 Apr; 190(8):4324-36. PubMed ID: 23479230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.
    Novelli L; Chimenti MS; Chiricozzi A; Perricone R
    Autoimmun Rev; 2014 Jan; 13(1):64-9. PubMed ID: 24021172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biologics for psoriasis: What is new?
    Özyurt K; Ertaş R; Atasoy M
    Dermatol Ther; 2019 May; 32(3):e12916. PubMed ID: 30972872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Th17 and Th22 cells in psoriatic arthritis and psoriasis.
    Benham H; Norris P; Goodall J; Wechalekar MD; FitzGerald O; Szentpetery A; Smith M; Thomas R; Gaston H
    Arthritis Res Ther; 2013 Sep; 15(5):R136. PubMed ID: 24286492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-17 and innate immunity in infections and chronic inflammation.
    Isailovic N; Daigo K; Mantovani A; Selmi C
    J Autoimmun; 2015 Jun; 60():1-11. PubMed ID: 25998834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies.
    Sánchez-Rodríguez G; Puig L
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis.
    Xue X; Soroosh P; De Leon-Tabaldo A; Luna-Roman R; Sablad M; Rozenkrants N; Yu J; Castro G; Banie H; Fung-Leung WP; Santamaria-Babi L; Schlueter T; Albers M; Leonard K; Budelsky AL; Fourie AM
    Sci Rep; 2016 Dec; 6():37977. PubMed ID: 27905482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-17 cytokines: Effectors and targets in psoriasis-A breakthrough in understanding and treatment.
    Prinz I; Sandrock I; Mrowietz U
    J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31727784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
    Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
    J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints.
    Boutet MA; Nerviani A; Gallo Afflitto G; Pitzalis C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29425183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenic role of IL-17 in psoriasis and psoriatic arthritis.
    Chiricozzi A
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():9-20. PubMed ID: 25398488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of brodalumab for the treatment of psoriasis and psoriatic arthritis.
    Kivelevitch DN; Menter A
    Immunotherapy; 2015; 7(4):323-33. PubMed ID: 25917624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation.
    Glatt S; Baeten D; Baker T; Griffiths M; Ionescu L; Lawson ADG; Maroof A; Oliver R; Popa S; Strimenopoulou F; Vajjah P; Watling MIL; Yeremenko N; Miossec P; Shaw S
    Ann Rheum Dis; 2018 Apr; 77(4):523-532. PubMed ID: 29275332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis.
    Raychaudhuri SK; Saxena A; Raychaudhuri SP
    Clin Rheumatol; 2015 Jun; 34(6):1019-23. PubMed ID: 25939522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.